| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-05 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |